Cadila Healthcare submits press release

24 Jul 2019 Evaluate

Cadila Healthcare has informed about submission of a copy of press release dated July 24, 2019 titled ‘Zydus has launched Ramelteon Tablets in the US upon receiving final approval from the USFDA’. The contents of the press release give full details.

The above information is a part of company’s filings submitted to BSE.

Zydus Lifesciences Share Price

348.80 3.65 (1.06%)
May 17, 15:33 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 892.70
Cipla 938.65
Dr. Reddy's Lab 3904.00
Aurobindo Pharma 536.25
Lupin 693.10
View more..